Noncurrent long-term debt increased 190.2%
Noncurrent long-term debt changed +190.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$28.8B→$83.7B4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →META financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Current assets increased 70.5%
Current assets changed +70.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$73.6B→$125.5B4 prior comparisons
Current liabilities increased 51.1%
Current liabilities changed +51.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$37.3B→$56.4B4 prior comparisons
Total assets increased 52.7%
Total assets changed +52.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$294.7B→$450.0B4 prior comparisons
Working capital increased 90.3%
Working capital changed +90.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$36.3B→$69.1B4 prior comparisons
Trade receivables increased 31.3%
Trade receivables changed +31.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$16.6B→$21.8B4 prior comparisons
Free-cash-flow proxy decreased 80.6%
Free-cash-flow proxy changed -80.6% from the comparable as-filed period.
$9.0B→$1.7B3 prior comparisons
Operating cash flow increased 24.7%
Operating cash flow changed +24.7% from the comparable as-filed period.
$25.6B→$31.9B3 prior comparisons
Operating margin moved 1214 bp lower
Operating margin changed -1214 basis points from the comparable as-filed period.
43.02%→30.88%2 prior comparisons
Revenue increased 28.0%
Revenue changed +28.0% from the comparable as-filed period.
$47.5B→$60.8B2 prior comparisons
Research & development increased 67.3%
Research & development changed +67.3% from the comparable as-filed period.
$12.9B→$21.7B2 prior comparisons
Current ratio increased 12.8%
Current ratio changed +12.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
1.97→2.234 prior comparisons
Capex / revenue moved 1473 bp higher
Capex / revenue changed +1473 basis points from the comparable as-filed period.
34.81%→49.53%2 prior comparisons
Capital expenditure increased 82.1%
Capital expenditure changed +82.1% from the comparable as-filed period.
$16.5B→$30.1B3 prior comparisons
Cash & equivalents increased 28.8%
Cash & equivalents changed +28.8% from the comparable as-filed period.
$12.0B→$15.5B2 prior comparisons
Stock-based compensation increased 57.2%
Stock-based compensation changed +57.2% from the comparable as-filed period.
$4.8B→$7.6B2 prior comparisons
Working capital / assets moved 304 bp higher
Working capital / assets changed +304 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
12.32%→15.36%4 prior comparisons
Operating income decreased 8.2%
Operating income changed -8.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$20.4B→$18.8B2 prior comparisons
SBC / revenue moved 233 bp higher
SBC / revenue changed +233 basis points from the comparable as-filed period.
10.17%→12.50%2 prior comparisons
Free-cash-flow margin moved 1612 bp lower
Free-cash-flow margin changed -1612 basis points from the comparable as-filed period.
18.99%→2.87%2 prior comparisons
Operating cash flow / net income increased 44.2%
Operating cash flow / net income changed +44.2% from the comparable as-filed period.
1.39→2.012 prior comparisons
R&D / revenue moved 838 bp higher
R&D / revenue changed +838 basis points from the comparable as-filed period.
27.24%→35.62%2 prior comparisons
Net income decreased 13.6%
Net income changed -13.6% from the comparable as-filed period.
$18.3B→$15.8B2 prior comparisons
Operating cash-flow margin moved 139 bp lower
Operating cash-flow margin changed -139 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
53.79%→52.40%2 prior comparisons
Receivables / revenue moved 92 bp higher
Receivables / revenue changed +92 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
34.85%→35.78%2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.